{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "regularMarketChangePercent": 4.387991, "regularMarketPrice": 226.0, "trailingAnnualDividendRate": 2.0, "trailingPE": 77.397255, "trailingAnnualDividendYield": 0.009237875, "epsTrailingTwelveMonths": 2.92, "sharesOutstanding": 68140000, "bookValue": 26.301, "fiftyDayAverage": 211.17, "fiftyDayAverageChange": 14.830002, "fiftyDayAverageChangePercent": 0.07022779, "twoHundredDayAverage": 204.405, "twoHundredDayAverageChange": 21.595001, "twoHundredDayAverageChangePercent": 0.10564811, "marketCap": 15399640064, "priceToBook": 8.592829, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1540515600000, "priceHint": 2, "marketState": "POSTPOST", "exchange": "TWO", "shortName": "EVER SUPREME BIO TECHNOLOGY CO ", "longName": "Ever Supreme Bio Technology Co., Ltd", "messageBoardId": "finmb_552939667", "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "tw_market", "esgPopulated": false, "regularMarketChange": 9.5, "regularMarketTime": 1684128639, "regularMarketDayHigh": 232.5, "regularMarketDayRange": "220.0 - 232.5", "regularMarketDayLow": 220.0, "regularMarketVolume": 8897509, "regularMarketPreviousClose": 216.5, "bid": 225.5, "ask": 226.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 221.0, "averageDailyVolume3Month": 1851321, "averageDailyVolume10Day": 1761000, "fiftyTwoWeekLowChange": 71.0, "fiftyTwoWeekLowChangePercent": 0.45806453, "fiftyTwoWeekRange": "155.0 - 277.5", "fiftyTwoWeekHighChange": -51.5, "fiftyTwoWeekHighChangePercent": -0.18558559, "fiftyTwoWeekLow": 155.0, "fiftyTwoWeekHigh": 277.5, "symbol": "6712.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 30, Keya Road", "address2": "4th Floor Daya District", "city": "Taichung", "country": "Taiwan", "phone": "886 4 2325 2888", "website": "https://www.ever-supreme.com.tw", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Ever Supreme Bio Technology Co., Ltd engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells. Its products include UMC01, a drug candidate in Phase I clinical trials for the treatment of myocardial infarction and stroke; ADCV01, a drug candidate in Phase II clinical trials for the treatment of malignant brain tumor; CAR001, a chimeric antigen receptor immune cells product; and bone-marrow stem cells (BMSC), used to treat chronic stroke, degenerative osteoarthritis, and spinal cord injuries. The company was incorporated in 2016 and is based in Taichung, Taiwan.", "companyOfficers": [], "maxAge": 86400}}], "error": null}}